Rapid Micro Biosystems (RPID) Revenue (2020 - 2026)

Rapid Micro Biosystems has disclosed Revenue across 7 years of filings, most recently posting $8.0 million for Q1 2026.

• Revenue for Q1 2026 came in at $8.0 million, up 11.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.4 million (up 15.99% YoY), and the FY2025 annual result was $33.6 million, up 19.74% from the prior year.
• Revenue came in at $8.0 million for Q1 2026 at Rapid Micro Biosystems, down from $11.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $11.3 million in Q4 2025 to a low of $3.9 million in Q2 2022.
• The 5-year median for Revenue is $6.3 million (2023), against an average of $6.4 million.
• Across the five-year window, Revenue sank 37.03% in 2022 and surged 44.88% in 2023, its largest moves.
• Rapid Micro Biosystems' Revenue stood at $4.4 million in 2022, then surged by 44.88% to $6.3 million in 2023, then grew by 29.68% to $8.2 million in 2024, then surged by 37.28% to $11.3 million in 2025, then slipped by 29.07% to $8.0 million in 2026.
• The last three Revenue figures came in at $8.0 million (Q1 2026), $11.3 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.